ALB and brain neoplasm: cRGD-MID-AC, cyclic RGD-functionalized closo-dodecaborate albumin conjugates with maleimide, has been shown to have a therapeutic effect in BNCT in an experimental F98 glioma-bearing rat brain tumor model.